RECENT NEWS

Innovative West Midlands health tech companies showcased their new developments, including an AI-powered sensor to be used after surgery to reduce hospital stays, to leading regional political figures.

Over 900 genetic links to osteoarthritis, including 500 that have never been reported before, have been uncovered in breakthrough research involving Sheffield Teaching Hospitals NHS Foundation Trust.

NHS clinicians will be supported to use ground-breaking AI tools that take notes, to free up staff time and deliver better care to patients, and the technology is being supported by new guidance from the government.

A bacteria killing coating created by scientists has been used in trials of a new paint that can be applied to a range of surfaces to effectively kill bacteria and viruses, including difficult to kill species such as MRSA, flu and COVID-19.

Immunisation efforts are under growing threat as misinformation, population growth, humanitarian crises and funding cuts jeopardise progress and leave millions of children, adolescents and adults at risk, warn WHO, UNICEF, and Gavi during World Immunisation Week, 24–30 April.

In a new study, published in The Lancet Neurology, researchers have found that using the Carotid Artery Risk (CAR) scoring system can help identify patients who can be effectively treated with a combination of medications and lifestyle changes tailored to their individual risk factors (otherwise known as optimised medical therapy).

The government is calling for men of all ages to come forward and feed into England’s first ever men’s health strategy.

Patients could soon benefit from world-leading technology to diagnose bowel cancer earlier, faster and cheaper, reducing the need for invasive colonoscopies and biopsies, and potentially saving valuable time and resource for the NHS, the government has announced.

Knowlex is hosting four essential conferences dedicated to advancing healthcare through infection prevention, patient safety, and innovation.

Research from the University of Cambridge shows that metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease.

Childhood exposure to a toxin produced by E. coli could be contributing to the rise of bowel cancer in under-50s, according to research funded by Cancer Research UK.

A 12-month roll-out has commenced to deliver the most significant update to UK clinical trials regulation in two decades – with the aim of strengthening patient safety, accelerating approvals, enabling innovation and helping more people benefit from taking part in vital research.

​Scientists from Northwestern University, in the US, have identified that piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment.

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, could provide a solution to problems with current TB screening, which does not always accurately detect disease.

Fatigue among NHS healthcare staff poses a significant yet under-recognised risk to patient safety, according to HSSIB’s latest investigation report.

The Association of Surgeons of Great Britain and Ireland (ASGBI) has announced its collaboration with the Royal College of Surgeons of Edinburgh (RCSEd) and Surgeons Quarter for the ASGBI International Surgical Congress.

The Association for Perioperative Practice (AfPP) has announced the appointment of Jody Carvell as the new Trent Regional Lead.

Eleven cutting-edge robotic surgery systems have been approved for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic procedures.

A new, independent survey of 2,000 UK adults, by nuom, has revealed growing concern among people with disabilities that the rise of AI in healthcare could lead to exclusion for those less confident with technology.

APIS Assay Technologies, a private UK based company specialising in molecular diagnostics, has announced the extension of the highly successful DEVOTE grant award from the UK Government’s Innovation Accelerator programme led by Innovate UK.